- Singapore pledges to support workers' mental health
- Fresenius Medical Care brings affordable dialysis to Cambodia
- Celltrion, Juno establish biosimilar partnership
- CNMPA approves Eisai's antiepileptic drug
- plano Eyecheck promotes global solutions for myopia, children eye care
- Lucence, TTSH to reduce risks of liver cancer surgery
- Dr. Steven Rosenberg's achievements in cancer immunotherapy motivate young researchers
- Roche reports strong sales growth in 2019
- Certara Celebrates 20th Anniversary of the Simcyp Simulator Consortium
- Avidity Science acquires Edstrom Japan Ltd
- GC Pharma, Vaxess team up for influenza vaccine smart release patch
- dMed to expand clinical operations capability
- Granules India to divest stake in Joint Venture in China
- BioIVT Acquires PPA Research Group enhancing its R&D capabilities
-
Specials | 27 September 2019 | Opinion
Building innovation in health: private sector is an essential partner
Asia has a long and proud history of innovation and today we live in a world which is characterized by breakne...Read more
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
-
Australia | 18 October 2019 | News
Celltrion, Juno establish biosimilar partnership
Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing p...Read more
-
Japan | 17 October 2019 | News
Dr. Steven Rosenberg's achievements in cancer immunotherapy motivate young researchers
Using the function of the individual's own immune system to combat cancer, this out-of-the-box concept was pro...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Improved regulatory support push Clinical Research in Asia
The prevalence of infectious and tropical diseases is creating an unmet clinical needs in emerging countries. Owing to these, a large number of the population participate in clinical trials to access high-quality healthcare free of cost. India and China have the highest prevalence rates for metabolic disorders, due to the increasing population, combined with the prevalence of insulin resistance, hyperlipidemia, and obesity. Besides the Asian region has the potential for large patient recruitment, cost reduction, the improved regulatory environment making it a favourable destination for clinical trials.
